ATE376422T1 - Diclazurilhaltige antiprotozoenmittel - Google Patents

Diclazurilhaltige antiprotozoenmittel

Info

Publication number
ATE376422T1
ATE376422T1 AT04701010T AT04701010T ATE376422T1 AT E376422 T1 ATE376422 T1 AT E376422T1 AT 04701010 T AT04701010 T AT 04701010T AT 04701010 T AT04701010 T AT 04701010T AT E376422 T1 ATE376422 T1 AT E376422T1
Authority
AT
Austria
Prior art keywords
antipprotozoal
diclazuril
agents
protozoal
compositions
Prior art date
Application number
AT04701010T
Other languages
English (en)
Inventor
Spiegeleer Bart De
Hilde Dosogne
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE376422T1 publication Critical patent/ATE376422T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
AT04701010T 2003-01-16 2004-01-09 Diclazurilhaltige antiprotozoenmittel ATE376422T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP0300398 2003-01-16

Publications (1)

Publication Number Publication Date
ATE376422T1 true ATE376422T1 (de) 2007-11-15

Family

ID=32695546

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04701010T ATE376422T1 (de) 2003-01-16 2004-01-09 Diclazurilhaltige antiprotozoenmittel

Country Status (11)

Country Link
US (1) US20060240049A1 (de)
KR (1) KR20050091062A (de)
AT (1) ATE376422T1 (de)
BR (1) BRPI0406795A (de)
CA (1) CA2512176A1 (de)
DE (1) DE602004009664D1 (de)
MX (1) MXPA05007601A (de)
MY (1) MY141593A (de)
PL (1) PL378713A1 (de)
TW (1) TW200507873A (de)
WO (1) WO2004062673A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
KR100683193B1 (ko) 2005-07-30 2007-02-15 주식회사유한양행 디클라주릴-함유 약제학적 조성물의 제조방법
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
CN102743334A (zh) * 2012-07-30 2012-10-24 郑州后羿制药有限公司 一种妥曲珠利注射剂及其制备方法
CN102973496B (zh) * 2012-11-22 2014-12-17 青岛绿曼生物工程有限公司 一种治疗家禽球虫病的地克珠利口服液的制备方法
CN105213311A (zh) * 2015-11-05 2016-01-06 南阳农业职业学院 地克珠利亚微乳的制备方法
DK3484476T3 (da) * 2016-07-13 2021-09-27 Univ Paris Meclozin-derivater til anvendelse ved forebyggelse og/eller behandling af lidelser associeret med den forårsagede inflammation
US10702475B2 (en) 2017-09-05 2020-07-07 Richard Rigg Liposome containing compositions and their use in personal care and food products
CN108904514B (zh) * 2018-07-26 2021-03-26 日照市牧邦畜牧科技有限公司 一种稳定长效复方地克珠利溶液

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3703103A1 (de) * 1987-02-03 1988-08-11 Bayer Ag Mittel gegen fischparsiten
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
WO1998043644A1 (en) * 1997-03-31 1998-10-08 David Granstrom Formulations and methods to treat and prevent equine protozoal myeloencephalitis
US6194408B1 (en) * 1998-12-22 2001-02-27 Bayer Corporation Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma

Also Published As

Publication number Publication date
MY141593A (en) 2010-05-14
WO2004062673A1 (en) 2004-07-29
BRPI0406795A (pt) 2006-01-17
KR20050091062A (ko) 2005-09-14
CA2512176A1 (en) 2004-07-29
MXPA05007601A (es) 2005-09-30
DE602004009664D1 (de) 2007-12-06
US20060240049A1 (en) 2006-10-26
TW200507873A (en) 2005-03-01
PL378713A1 (pl) 2006-05-15

Similar Documents

Publication Publication Date Title
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
SG155967A1 (en) Hcv ns3-ns4a protease inhibition
BRPI0414176A (pt) inibidores de serina proteases, em particular hcv ns3-ns4a protease
ATE349463T1 (de) Verbrückte bizyklische serinproteaseinhibitoren
ATE391708T1 (de) Verbindungen und gemische zur verabreichung eines aktiven agens
TW200510391A (en) Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
EA200200778A1 (ru) СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ГЕПАТИТА С В ОРГАНИЗМЕ ХОЗЯИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ПРОТИВ ФЛАВИВИРУСА, СОЕДИНЕНИЕ ФОРМУЛЫ Ib - АКТИВНЫЙ АГЕНТ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ГЕПАТИТА С ИЛИ ФЛАВИВИРУСА (ВАРИАНТЫ)
NZ504986A (en) Erythromycin and azalide derivatives and pharmaceutical compositions thereof, useful as antibacterial agents and antoprotozoa agents
TW200612898A (en) Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
MXPA04003825A (es) Inhibidores de serina proteasa, en particular la ns3-ns4a proteasa del virus de hepatitis c, que incorpora un sistema de anillo fusionado.
MY148690A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
WO2005007681A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
MXPA05008126A (es) Inhibidores de girasa y uso de los mismos.
BRPI0515896A (pt) composto ou um sal ou éster farmaceuticamente aceitável do mesmo, método para o tratamento ou profilaxia de um hospedeiro infectado com uma infecção por flavivìrus, pestivìrus ou hepacivìrus, e, composição farmacêutica para o tratamento de um hospedeiro infectado com uma infecção por flavivìrus, pestivìrus ou hepacivìrus
ATE360631T1 (de) Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
CR20220675A (es) Análogos de nucleósido de 1´- ciano y usos de los mismos
ATE548034T1 (de) Pharmazeutische zusammensetzungen mit droxidopa
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
MXPA05012247A (es) Derivados de bencimidazol nuevos.
BRPI0514250A (pt) uso de um composto, composição farmacêutica que compreende o mesmo, compostos e método de tratamento
ATE376422T1 (de) Diclazurilhaltige antiprotozoenmittel
NO20033959L (no) Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon
RU2009111387A (ru) Фармацевтические композиции для лечения грибковых инфекций
MXPA04011835A (es) Tratamiento de combinacion para la depresion y ansiedad.
EE200200688A (et) Akrüloüüldistamütsiini derivaati, mikrotuubulivastast toimeainet ja/või antimetaboliiti sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritud ravimpreparaat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties